Thugh devlces that can measure glucose level and
Introduction
Improperly managed, diabetes can lead to complications such as n a v e damage. brain damage, amputation and eventually death. Diabetes related complications are a worldwide epidemic with high medical. economic and social costs 11-31, Tight control of blood glucose levels has also been shown to reduce the mortality of diabetic, and non-diabetic, intensive care unit patients by up to 50% [4].
Diabetic individuals monitor food intake and daily activity to maintain blood sugar levels at an adequate level.
Far ease of management subjects are encouraged to stick to strict routines and diets to minimize manual monitohg and injections, reducing intervention and difficulty. However, this regime can lead to severe limitation of the subjects' lifestyle, an "'institutional" psychology, and the difficulty of consistently maintaining a strict daily regimen over several years.
administer insulin exist, they do just &at -measure and inject -with no automated interface between the two.
Current treatment for Type I diabetes involves monitoring the plasma glucose level and injecting insulin as Deeded. Normally, patients follow a strict regimen to prevent complications, however the effectiveness of this regimen is a function of thc patient*s inidtion and experience. A typical day for a diabetic individual might involve injecting long-acting insulin approximately three times and injecting rapidacting insulin before meals, to reduce the post-prandial blood glucose spike. The patient is required to make intuitive decisions when they deviate from normal diet or exercise panems, and modify their regimen to suit the irregularity. As a result, error is introduced and control is often not optimal.
Most commonly available glucose sensing devices operate by measuring the blood glucose content of a small finger-prick blood sample, an irritating method upon frequent use. As a result, some diabetic individuals measure blood sugar as inkquently as once per dpy, or less. However, recent advances have resulted in semi-invasive systems such as the GlucbWatoh Biographer from Cygnus [5]. This device offers sampling rates up to one reading every 20 minutes, and can measure and store data continuously for up to I2 hours before new sensor pads are required.
'Cment diabetes management typically seeks to limit blood glucose levels to less than 5.8-6.0 mmoVL, however tighter control to the basal level of 4.5-5.0 mmol/L would significantly limit the damage that results from long-tenn exposure to elevated blood glucose levels. The acceptance ofhigher blood glucose levels is considered ncceptable, as hlwd @ucose management without advanced sensors does not deliver the data or t h e capability to constantly modify insulin infusion rates to achieve tighter control. However, regular. automated blood glucose measurement provides the consistent volume of data necessary for such tight control, in contrast to the sonietimes infrequent and inconsistent self-measurement reported by clinicians.
Automation can also have a significant impact on the treatment of juveniles with Type I diabetes as children have less ability to fully manage the diseuse and, as a result, the stress and difficulty of management can fall on parents and others. In all cases, an automated approach can provide clinical staff with a far greater abundance, and consistency of data, enabling more effective treatment and feedback.
Whether it is in the area of understanding, modeling or managing diabetes [6, 7] Optimal wntrol using grid search theory, robust H-infdty control, and variable structure wntrollers have also been studied, each using different models [I I, 24.281. In each case, the focus has been on controlling absolute blood glucose excursion rather than slopes. The models used typically require either patient specific parameters that are not readily available andlor knowledge of glucose or exenise inputs that would not be known a priori for an ambulatory individual. Finally, none study the impact of more frequent measuremeot enabled by recent advances in sensing technology or the potential for improved results.
Glucose Regulatory System Model
Comprehensive models, though very accurate for regimen evaluation, are generally unsuited for real-time control, requiring several time points of input to generate the insulin infusion profde. Additionally, they are not generic requiring-patient-specific data and known glucose inputs. The aim of this research is to develop wntrol schemes based on models that capture the essential system dynamics, do not require unavailable data, and are applicable to a wider variety of subjects. Simple models capture these essential dynamic behaviours, providing a more suitable foundation for real-time control design and analysis.
A well know and more importantly, physiologically verified model originated eom the work of B e r g " et al. [15] . It utilises the concept of a remote compartment for the storage of insulin to acwunt for the time delay between injection of insulin and its utilizatkn to reduce blood glucose levels. Equations (1)-(3) show the equations used to defme the system. The model is simple, yet accurately represents the essential dynamics of the human glucose regulalory system. The three equations represent insulin production and infusion, insulin storage in a remote compartment, and glucose input and insulin utilization in a second compartment The values of n. Vi, G , IB employed are defined, for an average-weighted male as: vi = 12 L, n = 51% min", cB = 4.5 mmol U', le = 15 m u L? [IO] .
The controller uses a simple feedback Imp that employs the blwd gluwse level above basal, G, and its derivative, G, as sensor inputs, and the exogenous insulin infusion rate, U#. as the control output. As a result, the controller measures the output from Equation (I) while directly influencing Equation (3) via the control action. In between are the time delay and dynamics of the remote compartment defined in Equation (2).
Controller Definition
There are many complex influences between glucose and insulin concentration for any person, normal or diabetic. However, the steady stnte glucose concentration in the body is fmaUy determined by how much insulin is present. In order to lower glucose concentration in the blood, insulin needs to be released, injected or infused. Hence, the &troller defmes the insulin infusion rate. U#, based on the measured inputs G andor d , The goal is to miniexcess glucose, G, and its rate of change, G, and enswe that excursions from the basal value, G, are minimised in magnitude and duration with no hypoglycemic overshoot below the basal level. Therefore, blood sugar levels must be maintained in a tight range around the 
Relative Proportional Control (RPC)
One of the better-known, more effective diabetes control systems is a relative proportional control law (RF'C) [IO] .
This basic, widely used form of proportional control law is based on the idea of strictly limiting the absolute blood sugar level by applying resisting "forces" (insulin) in weighted proportion to the magnitude ofthe excursion from the desired (basal) level. The control inputs are defined:
This controller is based on a relative proportional control (G/G,,) with a constant term Note that when G = Gh die blood sugar is at the desired level and the insulin infusion rate is U , , , the basal infusion rate necessary to maintain blood glucose at a constant level.
Heavily Weighted Derivative Controller
This controller uses a PD control law where the derivative gain is lwge and the proportional gain is much smaller.
Where Equation (5) incorporates proportional and derivative control with independent gains to weight the different terms and the hasal infusion U".
Heavy emphasis implies that the derivative gain, ! q . is significantly larger than the proportional gain, kv As a result, this controller focuses almost exclusively on controlling the slope of the blood glucose c m e rather than its absolute magnitude. This approach is far different than normally taken and made possible by the emerging capability to measure blood sugar far more regularly via semi-or non-invasive methods. The gains will of course vary with sensor sampling rate.
There are several benefits provided by derivative emphasized control for this non-linear, delayed system.
Most importantly, a large increase in glucose is observed before a large proportional tmn, enabling a faster response time for the controller, This approach implies that the sooner insulin is infused, or injected, the earlier it can be utilized to reduce blood glucoseanalogous to the thinking behind current diabetes injection regimes. In addition, flattening the slope of the glucose response provides an effective, implicit means of minimizing the (eventual) magnitude of the entire glucose response before it rises to high.
Derivative terms can be susceptible to noise, but in this case with appropriate filtering and technology it should not be an iswe.
Numerical Tests and Verification
This sectioa presents the numerical verification of the control systems presented by simulating oral glucose tolerance tebting. Comparisons am also made to normal human response.
Oral Glncose Tolerance Test
The oral glucose tolerance test (OGTT) is a large step input test of the glucose regulatory system often performed to diagnose diabetes. A fasting subject consumes 400-800 calories of glucose and the response is observed. This beta-cell function test represents a significant challenge to the pancreas and measures the insulin response capability. The OGTT glucose input may be modelled by the lognormal distribution d e f d in Equation (6).
Where Pm is L e p& value and a, b and e are constants, which determine the exact shape. This function is employed because it is smooth, continuously differentiable, has zero initial conditions, is easily implemented, and physiologically accurate. It is easily modified to represent different absorption rates of exogenous glucose. .
.' I .., Figure 2 shows the insulin infusion profile for the RPC and PD controller responses shown in Figure 1 . The step function shape is due to the 20-minute sampling interval employed and the resulting 20-minute interval between changes in infusion rate. Note that as the sampling interval shrinks the insulin profiles for the PD controllers get smoother and sharper, with a shape more like that of an insulin injection profile.
In judging controller performance the critical factors arc the magnitude of the excursion for a given input and the time required to return to basal blood sugar levels. The PD controller limits the excursion and returns to the basal level much faster, in each case, due to the higher infusion rates generated by large initial slopes of the glucose cune. Figure 2 also shows that as the sampling rate increases, the insulin infusion profile for the PD wntroUer tends to mimic the sharper spike of an injection profde. These results match. The comparison to normal glucose response is also important. Figure I shows that the PD controller, due to its rapid insulin input, outperforms normal response in terms of both magnitude and duration of the glucose excursion from basal level. The RPC controllers both have response similar to the normal curve, but with higher magnitude, indicating that the human glucoregulatory system is likely a primarily proportional based control system. The 20-minute sampling interval PD controller has higher magnitude, as discussed previously, hut much shorter duration. However, this difference is offset by a smll amount of hypoglycemic overshoot for the PD controller lhat results from the longer sampling interval in the feedback loop.
Finally, a GlucoWayarch sensor measurement lags approximately one sample period due to the method by which it obtains the value. Simulation with this additional lag was simulated with a 20-minute sampling period for the PD controller to determine its impact on control efficacy. As expected, contml response lags further allowing greater glucose excursions in both magnitude and duration when compared to the results shown in Figure I . However, this lag impacts the results of proportional and derivative weighted cantrollen alike. Similar results are seen when accounting for 1-3 sample period failures in the sensor.
Comparison of Control Methods
It is seen that the heavy derivative PD contmller outperfom the RPC. The RPC defdtion in Equation (4) has a gain of 1.0 on the relative proportional term.
However, as this gain is increased for better peak performance hypoglycemic overshwt grows because even as the glucose levels are decreasing toward basal a proportional conlroller is still infusing insulin. The result is hypoglycemia due to over-insulinising a system with significant delay.
Hence, simply increasing proportional gain is not a practicable solution. in genenl unless explicitly and exactly accounting for the time delays of the system. The PD controller, which is able to command sienificant insulin infusion earlier than a orooortional -. . Figure I , iuustrates the impact of new sensor technology and the improvements it can enable in glucose response as the sampling interval rises because the derivative large defivative the PD contro~~er cuts the insulin enables better control and, with meater sensor bandwidth, drives the control input to match current, effective diabetes management with infusion profiles that are essentially pre-meal injections with a basal infusion rate at other times.
In terms of the insulin infusion profiles shown in Figure 2 the 
Conclusions
The emergence of glucose sensors capable of providing blood glucose readings at a very high rate is investigated for their ability to automate insulin infusion for diabetic individuals, by opening the possibility of controlling the slope of the glucose responsc curve, rather than focusing strictly on absolute blood glucose level. A simple PD controller where the derivative term heavily outweighs the proportional term is shown to be highly effective. A proportional-based controller is also simulated to highlight the effectiveness of controlling the slope of the glucose curve rather than the absolute blood glucose level. The impact of different sampling periods, sensor lag, and the relative impact of proportional and derivative control is delineated.
The primary result is that a simple PD controller, heavily emphasising the derivative term, can effectively and robustly manage a variety of glucose input profiles slightly better than even a normal person.
More specifically, the PD controller is shown to control glucose excursions up to 50% better than proponionalbased control schemes and slightly better than the normal human system as represented by the model employed.
The comparisons with the normal physiological response indicates that an approximation of the normal physiological glucose regulation system is primarily proportional control with some measure of derivativr control to eliminate or minimize any hypoglycemic overshoot.
Finally, as the sampling period drops, the insulin infusion profiles for this type of PD controller mimic current diabetes management utilizing pre-meal injections and low infusions at other times, verifying the hasic approach. As a result, far tighter control of blood glucose excursions from basal levels can be used to reduce the impact of long-term exposure to (slightly) elevated blood glucose levels and increase the consistency of treatment. Ongoing research is focused on developing the protocol for testing this algorithm under controlled circumstances using ICU and ambulatory diabetic individuals. 
